Jabbawockie Content

3 years ago
146

Jabbawockie Content

They Changed the name from
chad0x1 to AZD1222
So people wouldn't think it was the same aborted fetal cells

https://www.drugs.com/history/azd1222.html

No Brand name: AZD1222
Generic name:
S A R S-C o V-2 va**ine Previous Name: ChAdOx1 nCoV-19 Company: As*traZene*ca Treatment for:

Prevention of C O V ID-19 AZD1222
(formerly ChAdOx1 nCoV-19)
is an investigational va**ine against
S A R S-C o V-2 in development for the prevention of C O V I D-19.

Chad0x1

https://en.wikipedia.org/wiki/ChAdOx1

https://www.who.int/publications/m/item/chadox1-s-recombinant-covid-19-vaccine

The MRC-5 cell line was developed in September 1966 from lung tissue
taken from a
14 week fetus aborted
for psychiatric reason from a 27 year old physically healthy woman.
The cell morphology is fibroblast-like.

https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/mrc5/mrc5cells.html

https://www.cga.ct.gov/2020/PHdata/Tmy/2020HB-05044-R000219-Wrinn%2015,%20Chris-TMY.PDF

AZD1222 In Over 30,000 Volunteers 13 AZD1222 5x1010 viral particles
2 IM doses N=20,000
Saline Placebo 2 IM doses N=10,000 Randomized
(2:1) N >30,000 •
Given by intra-muscular injection, 0.5 ml •
Study ongoing in the US, Chile and Peru (NCT04516746. ClinicalTrials.gov website)

https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-01/02-COVID-Villafana.pdf

https://www.stopworldcontrol.com/downloads/en/vaccines/vaccinereport.pdf

Loading 3 comments...